.Duration of therapy with azacitidine in MDS
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update / Silverman LR; Fenaux P; Mufti GJ; Santini V; Hellström-Lindberg E; Gattermann N; Sanz G; List AF; Gore SD; Seymour JF; Backstrom J; McKenzie D; Beach CL.. - In: ECANCERMEDICALSCIENCE. - ISSN 1754-6605. - STAMPA. - 2:(2008), pp. 118-118. [10.3332/ecancer.2008.118]
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update.
SANTINI, VALERIA;
2008
Abstract
.Duration of therapy with azacitidine in MDS
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
manuscript.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
125 kB
Formato
Adobe PDF
|
125 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
